---
title: "Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors"
collection: publications
permalink: /publication/2021-IDH-NAR-Cancer
excerpt: 'Discovery of synergistic DNA repair inhibitor combinations for targeting oncometabolite-producing cancers. [Editor's Choice]'
date: 2021-06-01
venue: 'NAR Cancer'
paperurl: 'https://doi.org/10.1093/narcan/zcab018'
citation: 'Sule A, Van Doorn J, Sundaram RK, Ganesa S, Vasquez JC, Bindra RS. (2021). &quot;Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors.&quot; <i>NAR Cancer</i>. 3(2):zcab018.'
---

Discovered and validated a synergistic combination of DNA repair inhibitors (ATR and PARP inhibitors) for targeting IDH1/2 mutant cancers. Selected as Editor's Choice.

[Download paper here](https://doi.org/10.1093/narcan/zcab018)

**Recommended citation:** Sule A, Van Doorn J, Sundaram RK, Ganesa S, Vasquez JC, Bindra RS. (2021). "Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors." <i>NAR Cancer</i>. 3(2):zcab018.
